Log in to save to my catalogue

Acetazolamide-Induced Periorbital Myokymia: A Case Report

Acetazolamide-Induced Periorbital Myokymia: A Case Report

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9792638

Acetazolamide-Induced Periorbital Myokymia: A Case Report

About this item

Full title

Acetazolamide-Induced Periorbital Myokymia: A Case Report

Publisher

United States: Cureus Inc

Journal title

Cureus, 2022-11, Vol.14 (11), p.e31920-e31920

Language

English

Formats

Publication information

Publisher

United States: Cureus Inc

More information

Scope and Contents

Contents

Acetazolamide, a carbonic anhydrase inhibitor, is primarily used in the treatment of glaucoma, due to its role in decreasing intraocular pressure by lowering the production of aqueous humor. Additionally, by lowering cerebrospinal fluid (CSF) production, it is also used in the treatment of raised intracranial pressure. Drug-induced myokymia has rar...

Alternative Titles

Full title

Acetazolamide-Induced Periorbital Myokymia: A Case Report

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9792638

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9792638

Other Identifiers

ISSN

2168-8184

E-ISSN

2168-8184

DOI

10.7759/cureus.31920

How to access this item